Compare BDX & FNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDX | FNV |
|---|---|---|
| Founded | 1897 | 1986 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.3B | 43.6B |
| IPO Year | 1997 | 2009 |
| Metric | BDX | FNV |
|---|---|---|
| Price | $156.14 | $215.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 8 |
| Target Price | $186.00 | ★ $248.13 |
| AVG Volume (30 Days) | ★ 2.3M | 993.1K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | ★ 2.89% | 0.69% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $21,840,000,000.00 | N/A |
| Revenue This Year | N/A | $55.98 |
| Revenue Next Year | $3.02 | $16.81 |
| P/E Ratio | $604.88 | ★ $53.29 |
| Revenue Growth | ★ 8.24 | N/A |
| 52 Week Low | $140.11 | $152.89 |
| 52 Week High | $213.08 | $285.67 |
| Indicator | BDX | FNV |
|---|---|---|
| Relative Strength Index (RSI) | 62.69 | 45.04 |
| Support Level | $153.27 | $203.10 |
| Resistance Level | $159.79 | $219.17 |
| Average True Range (ATR) | 3.73 | 7.69 |
| MACD | 0.93 | -0.12 |
| Stochastic Oscillator | 94.70 | 33.45 |
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Franco-Nevada Corp is a precious-metals-focused royalty and investment company. The company owns a diversified portfolio of precious metals and royalty streams, which is actively managed to generate the bulk of its revenue from gold, silver, and platinum. The company does not operate mines, develop projects, or conduct exploration. The company's short-term financial performance is linked to the price of commodities and the amount of production from its portfolio of producing assets. Its long-term performance is affected by the availability of exploration and development capital. The company holds a portfolio of assets, diversified by commodity, revenue type, and stage of a project.